Ledger.Open graph →
SEC Form D · filed March 17, 2016

Envisia Therapeutics, Inc

Offering
$16.5M
Sold
$10.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MORRISVILLE, NC
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Eric Linsley · MORRISVILLE, NCExecBen Yerxa · MORRISVILLE, NCExecGary Phillips · MORRISVILLE, NCDirectorEd Mathers · MORRISVILLE, NCDirectorNeal Fowler · MORRISVILLE, NCDirectorStephen Bloch · MORRISVILLE, NCDirectorWilliam Yelle · MORRISVILLE, NCDirectorRobert Cryan · Lake Forrest Park, WADirectorRonald C. Filer, Jr · Hendersonville, TNExecWilliam L. Moore · Hendersonville, TNDirectorChristopher S. O'Connor · Wildwood, MODirectorTed Smith · Crestwood, KYDirectorAdrienne Graves · San Diego, CADirectorCharles Heffernan · Seattle, WADirectorKarl R. Miller, Jr · Wilsonville, ORExec · DirectorMahmood Sher-Jan · Portland, ORExecLance De Jersey · St. Peter Port, Y7DirectorMichael Studer · St. Peter Port, Y7DirectorDaniel Stopher · St. Peter Port, Y7ExecWilliam Yelle · MORRISVILLE, NCDirectorAdrienne Graves · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗